Professional Overview
Lance Hepler serves as Co-Founder, leveraging his expertise in computational biology and bioinformatics to drive innovation. His key areas of expertise include genomics, bioinformatics, and computational biology, with a focus on the biotechnology industry.
Experience Summary
Current Role
As Co-Founder at Infinimmune, Lance is responsible for shaping the company's strategic direction and overseeing the development of novel biotechnological solutions. Since assuming this role in 2022, he has been instrumental in fostering a culture of innovation and collaboration.
Career Progression
Lance's career is marked by notable roles that have contributed to his growth as a professional. Prior to co-founding Infinimmune, he served as a Staff Computational Biologist at 10X Genomics from 2018 to 2022 and as a Staff Engineer, Bioinformatics at Pacific Biosciences from 2013 to 2018. These roles have equipped him with a deep understanding of the biotechnology landscape and the ability to develop cutting-edge solutions.
Areas of Expertise
Lance possesses industry-specific skills in genomics, bioinformatics, and computational biology. His technical competencies include expertise in programming languages, data analysis, and algorithm development. As a co-founder, he has also demonstrated leadership and management capabilities, guiding teams towards achieving strategic objectives.
Professional Impact
Throughout his career, Lance has contributed to numerous projects and initiatives that have advanced the field of biotechnology. His work has focused on developing innovative solutions that address complex biological questions, with a particular emphasis on genomics and bioinformatics.
Conclusion
Lance Hepler's professional trajectory is characterized by a steady progression of innovative contributions to the biotechnology industry. Currently focused on driving growth and innovation at Infinimmune, Lance brings a unique combination of technical expertise, leadership capabilities, and strategic vision. His value proposition lies in his ability to bridge the gap between technological innovation and real-world applications, making him a valuable asset to the biotechnology community.
